Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,359 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07488377Recruiting
Cognitive Self-Confidence in Parkinson's Disease
This study tests a new questionnaire to measure how confident people with Parkinson's feel about their thinking and memory. It may help doctors better understand and support cognitive changes in Parkinson's.
Istanbul, TurkeyAges 40–85 - NCT07483047Recruiting
Predicting memory changes after heart surgery in older adults
This study looks at older adults having heart surgery to find out who might have trouble thinking or remembering afterward. Researchers hope to build a tool to predict this risk so doctors can help sooner.
ShanghaiAges 65 years+ - NCT06776133Recruiting
Predicting heart pressure from vein size in children
This study looks at a possible link between the size of a large vein (the inferior vena cava) and the pressure in the right side of the heart in children. If the link is strong, doctors might one day use vein size to estimate heart pressure without more invasive tests.
Bologna, BolognaAges Up to 18 years - NCT06777914Recruiting
Genes linked to rare liver disease and cancer risk
This study looks at whether certain family-related genes make people more likely to develop liver or bile duct cancers without a clear cause. If you had surgery or a transplant for one of these cancers and have had unexplained high liver enzymes or itching, this trial may help find genetic clues.
Bologna, BolognaAges 1 year+ - NCT07473700RecruitingPhase 2
Study of TX000045 for lung scarring and high blood pressure in the lungs
This trial tests a new medicine called TX000045 for people who have both lung scarring (interstitial lung disease) and high blood pressure in the lungs (pulmonary hypertension). It aims to see if the drug can help improve breathing and daily function.
Phoenix, ArizonaAges 18–80 - NCT07473323RecruitingPhase 1
Testing a new drug for healthy adults and those with diabetic kidney disease
This trial tests a new medication called MTX-439. It includes healthy adults and people with diabetic kidney disease to see if the drug is safe and to learn how the body handles it.
Melbourne, VictoriaAges 18–65 - NCT07478354Recruiting
Heart Tissue and Blood Study for Pediatric Heart Disease
This study collects samples (blood, tissue, and other specimens) from people of all ages who have or are at risk for pediatric heart disease. The goal is to build a research bank to better understand these conditions and develop new treatments.
Cincinnati, OhioAges Any age - NCT07479186Recruiting
How aortic disease affects quality of life and work
This study looks at how having an aortic disease (a problem with the main artery from your heart) impacts your daily life and ability to work. It aims to help doctors better understand and support patients like you.
Roma, RMAges 18–70 - NCT07479810Enrolling by invitation
Chronic disease care study for older adults
This trial looks at how primary care teams can help people over 65 manage long-term health conditions that are not cancer. It may help you get better support from your doctor and local health services.
Lonigo, VicenzaAges 65 years+ - NCT07471984Enrolling by invitation
Checking how AI reads brain scans for better diagnosis
This study tests a new AI tool to see if it can help doctors better understand brain MRI and CT scans. It may find issues like strokes, bleeding, tumors, or injuries.
BeijingAges Any age - NCT07480720Recruiting
Thyroid autoimmunity and eye changes in Graves disease
This study looks at how inflammation and thyroid autoimmunity in Graves disease may cause changes in the retina at the back of the eye. It uses a special eye scan (OCT) to measure those changes and compares results between people with Graves disease and healthy volunteers.
Elâzığ, ElaziğAges 18 years+ - NCT07472049Recruiting
Imaging plaque activity in peripheral artery disease
This trial studies plaque activity in leg arteries using a new imaging method to understand artery disease better. It may help people with peripheral artery disease get more targeted treatment.
Edinburgh, MidlothianAges 18 years+ - NCT07477431RecruitingPhase 2
Testing levetiracetam for those at risk of Alzheimer's
This trial tests if a medication called levetiracetam (a drug usually used for seizures) can help protect memory in people who are at higher risk for Alzheimer's but do not yet have memory problems. It involves brain scans and cognitive tests to see if the drug can reduce overactive brain activity linked to memory loss.
Toronto, OntarioAges 55–85 - NCT07474220Recruiting
Study of SLC25A48 in COPD
This study measures a protein called SLC25A48 in people with COPD (a lung condition that makes breathing hard) and in healthy people to learn if it plays a role in the disease.
New Taipei CityAges 18 years+ - NCT07478614Recruiting
Study of treatments for adenomyosis pain and heavy bleeding
This study follows people with adenomyosis to see which treatments work best for pain and heavy bleeding. It may help doctors find better ways to manage symptoms.
PotenzaAges 20–50 - NCT07475741Recruiting
Exergaming for better arm and hand function in Parkinson's
This trial tests whether exergaming (video games that involve physical movement) can improve arm and hand function in people with early-stage Parkinson's disease. It may help you move better and do daily tasks more easily.
Lahore, Punjab ProvinceAges 45–85 - NCT07478146Recruiting
Aerobic exercise for brain and movement in Parkinson's
This study tests whether moderate aerobic exercise (like brisk walking or cycling) can improve thinking, memory, and walking ability in people with Parkinson's disease. It also looks at how exercise affects blood flow in the brain.
São Paulo, São PauloAges 40 years+ - NCT07480512Recruiting
A study on causes and outcomes of coronary artery disease
This study follows people with different types of coronary artery disease over time to understand what causes their condition to get better or worse, and how well they do. The goal is to improve future treatment and care.
Guangzhou, GuangdongAges 18 years+ - NCT07477509Recruiting
Northwestern neuromuscular disease tissue and blood bank
This study collects tissue and blood samples from people with nerve or muscle disorders to help researchers learn more about these conditions. The goal is to build a bank of samples for future studies.
Chicago, IllinoisAges 18 years+ - NCT06779799Recruiting
Study of vocal cord lesions in autoimmune disease patients
This study examines vocal cord lesions, like 'bamboo' nodes, that cause voice changes (dysphonia) in people with autoimmune diseases such as lupus or rheumatoid arthritis. It aims to better understand and characterize these lesions to improve diagnosis and treatment.
BrestAges 18 years+ - NCT06626308Recruiting
Early signs in Huntington’s gene carriers study
This study looks for early changes in the body and brain of people who carry the Huntington’s disease gene but don’t yet have symptoms. It may help find better ways to track the disease early.
GrenobleAges 18–70 - NCT06075979Recruiting
Microbes and spine health: a surgical study
This study looks at whether certain microbes (tiny living things) are linked to spine problems like herniated discs or narrow spinal canals. It involves people who need spine surgery, and the findings might help explain why some spines wear out faster.
Jinan, ShandongAges 18–85 - NCT05530070Recruiting
Study diet effects on heart risk in celiac disease
This study looks at how celiac disease and gluten-free (GFD) or gluten-containing diets affect blood and cardiovascular (heart and blood vessel) risk factors. It may help researchers understand which diet habits are most important for heart health in people with celiac disease.
Pécs, BaranyaAges 18 years+ - NCT06702124RecruitingPhase 3
Rotigotine patch with rivastigmine for mild to moderate Alzheimer's
This trial tests if adding a rotigotine patch to your usual rivastigmine treatment can help with symptoms of Alzheimer's. It is for people with mild to moderate Alzheimer's who have been stable on rivastigmine for at least 3 months.
Rome, ItalyAges 50–85
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,359 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.